Skip to search.
 TSX Up 0.30% TSX Ventures Down 0.15%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
32.08 Down 0.01(0.03%) Jul 2, 4:00PM EDT
Add to Portfolio
Prev Close:32.09
Open:32.00
Bid:N/A
Ask:34.50 x 200
1y Target Est:43.78
Beta:1.14
Next Earnings Date:30-Jul-15ACOR Earnings announcement
Day's Range:31.60 - 32.20
52wk Range:28.26 - 45.45
Volume:359,339
Avg Vol (3m):622,125
Market Cap:1.37B
P/E (ttm):96.92
EPS (ttm):0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
ACORDown 0.03%1.37B
BIIBDown 0.28%95.10B
TEVAUp 1.00%52.20B

Key Statistics

Forward P/E (1 yr):34.49
P/S (ttm):3.26
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :0.58
Quarterly EPS Est (Jun-15) :0.17
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):1.49

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback